跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 225 条关于
“Transferrin”
全部
225
临床试验
53
药物
14
机构
0
资讯
158
去年
PulseSight Therapeutics Initiates Clinical Development of Novel Transferrin Therapy for Geographic Atrophy
9个月前
Acumen Pharmaceuticals Demonstrates 68-Fold Increase in Brain Delivery for Alzheimer's Antibody Using Novel Transferrin Receptor Technology
去年
Transferrin Receptor-Targeted ASOs Show Promise in Crossing the Blood-Brain Barrier
去年
PulseSight Therapeutics Presents Promising Data on PST-611 for Dry AMD/Geographic Atrophy
去年
PulseSight Therapeutics to Present PST-611 Data for Dry AMD at EVER Congress 2024
去年
Nanocarrier Technology Shows Promise for Alzheimer's Disease Treatment by Overcoming Blood-Brain Barrier
去年
FDA Lifts Clinical Hold on Ocugen's OCU200 Phase 1 Trial for Diabetic Macular Edema
7个月前
PulseSight Therapeutics Completes Phase I Dosing for Novel Gene Therapy PST-611 in Geographic Atrophy
去年
Novel Nanoparticle Formulations Enhance Paclitaxel Delivery to Cancer Tumors
去年
JCR Pharmaceuticals Completes Enrollment in Global Phase III Trial for Blood-Brain Barrier-Penetrating Hunter Syndrome Therapy
第 1 页,共 16 页
上一页
下一页